Cyxone AB
CYXO | ST
Overview
Corporate Details
- ISIN(s):
- SE0007815428 (+2 more)
- LEI:
- 54930034OH16ROAY4K87
- Country:
- Sweden
- Address:
- Hyllie Boulevard 34, 215 32 Malmö
- Website:
- https://www.cyxone.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Cyxone AB develops disease-modifying therapies for autoimmune diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Cyxone AB filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Cyxone AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cyxone AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-06-28 | Carl Magnus Högerkorp | Other | Buy | 64,950 | 40,788.60 SEK |
| 2023-06-27 | Carl Magnus Högerkorp | Other | Buy | 6,050 | 3,690.50 SEK |
| 2023-03-03 | Carl Magnus Högerkorp | Other | Buy | 100,010 | 51,005.10 SEK |
| 2023-03-02 | Carl Magnus Högerkorp | Other | Buy | 10,873 | 5,653.96 SEK |
| 2021-07-15 | Bert Junno | Other | Other | 1,788,732 | 7,763,096.88 SEK |
| 2021-07-15 | Bert Junno | Other | Other | 1,788,732 | N/A |
| 2021-07-14 | Bert Junno | Other | Other | 1,788,786 | 7,790,163.03 SEK |
| 2021-07-14 | Bert Junno | Other | Other | 1,788,786 | N/A |
| 2021-07-12 | Mikeoo Holding AB | Other | Other | 1,788,732 | 7,441,125.12 SEK |
| 2021-07-12 | Mikael Lindstam | Other | Other | 1,788,732 | N/A |
Peer Companies
Company
Country
Ticker
View
Develops AI-powered, non-invasive systems for allergy diagnostics & personalized medicine.
Poland
MTN
Poland
MTN
Pioneering DARPin protein drugs for complex diseases in oncology and virology.
Switzerland
MOLN
Switzerland
MOLN
Biopharma company creating antibody therapies for oncology, with a focus on blood cancers.
Germany
MOR
Germany
MOR
Developing a nanoparticle delivery system for advanced gene and vaccine therapies.
United Kingdom
N4P
United Kingdom
N4P
R&D of biotech medical devices for diabetes care and topical skin treatments.
Israel
NXGN
Israel
NXGN
Developing innovative ophthalmology drugs for glaucoma and ocular hypertension.
France
COX
France
COX
Antibody biomarker discovery platform for pharma and biotech partners in oncology and autoimmune disease.
United Kingdom
ONC
United Kingdom
ONC
Sweden
ONCOZ